The following product(s) are being reference priced from 1 April 2019, which comes about from an alternative being award the Sole Supply within the next few months.

We are highlighting these so that you have time to manage the transition.

No price support provided for the following therefore price will not be reduced until stocks in the supply chain currently are depleted. We will replace automatically to new brand at that time.

Pharmacode 2129264 Moclobemide-Apo Tab 150mg 500 from $85.10 to $53.34 and delisting 1 July 2019

Pharmacode 2129272 Moclobemide-Apo Tab 300mg 100 from $30.70 to $18.42 and delisting 1 July 2019

Pharmacode 2087081 Lioresal Intrathecal Inj 2 mg/ml 5 ml ampoule from $209.29 to $74.60 and delisting 1 August 2019

As of the date of this notification ProPharma / PWR cannot accept any of the above listed products for credit under any circumstances.

About The Author